Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial of Lyophilized Live Attenuated Varicella Vaccine for Children Aged 1-12 Years

NCT06614816 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT06614816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06614816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial of Lyophilized Live Attenuated Varicella Vaccine for Children Aged 1-12 Years
Lead sponsor
Southeast University, China
Phase
Phase 3
Overall status
Completed
Start date
February 10, 2019
Completion date
June 20, 2022
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chickenpox vaccines